Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
March 2014—Central Ohio–based Mount Carmel Health System has partnered with Chi Solutions to offer enhanced quality laboratory outpatient services for existing physicians, clients, and customers, and to provide a highly competitive laboratory offering to market-at-large physicians.
March 2014—Streck’s Cell-Chex Auto is now assayed for Siemens Healthcare Diagnostics’ Advia 120/2120/2120i instrument system. Cell-Chex Auto is a three-level spinal and body fluid control for evaluating the accuracy and precision of hematology instruments that measure blood cell counts in patient body fluid samples.
March 2014—Enzo Life Sciences’ Histamine ELISA kit provides a quantitative detection method for measuring histamine in human, rat, mouse, and canine samples. Because of histamine’s potent role in the immune response, it is present in a transitory state in the body and can only be measured within minutes of release. The half-life of histamine in a biological system is four minutes before its conversion to n-methyl histamine.
September 2014—Ohaus will launch in September its Adventurer line of analytical and precision balances for standard laboratory weighing. Adventurer has nine application modes, including weighing, percent weighing, counting, check weighing, dynamic weighing, totalization, formulation, density determination, and display hold.
September 2014—EKF Diagnostics highlighted its expanding product portfolio at its subsidiary’s booth, Stanbio Laboratory. DiaSpect Tm, which previewed at the meeting, is a palm-sized hemoglobin measurement system that gives laboratory-quality performance for anemia screening. Delivering results in one to two seconds, this analyzer is CE marked and currently undergoing FDA approval.
February 2014—Streck’s A1c-Cellular, a whole red blood cell A1c control with intact red blood cells, is now assayed for the Abbott Architect Integrated ci Systems. A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cell.
February 2014—Protagen has entered into a long-term collaboration agreement with Qiagen to target the development of novel protein-based companion diagnostics for autoimmune disorders. Under the terms of the agreement, Qiagen will gain access to Protagen’s proprietary SeroTag technology platform, which enables the discovery and validation of novel protein-based marker panels.
February 2014—Title21 Health Solutions released its Cellular Therapy Solution, which enables cellular therapy environments, transplant centers, and cord blood banks to achieve traceability, enhance quality controls, and streamline the life cycle of therapeutic products in an easy-to-use platform.
February 2014—Chembio Diagnostics has entered a follow-on, milestone-based development agreement with a private contracting organization acting on behalf of the Centers for Disease Control and Prevention for a multiplex POC influenza immunity test using Chembio’s patented Dual Path Platform technology.
February 2014—Nikon Instruments announced a strategic partnership between Nikon and Jeol to research and develop tools that can correlate light and electron microscopy data to further push the limits of resolution.
